Press release
Alzheimer’s Drugs Market to Record Sturdy Growth by 2025
According to Transparency Market Research, the global market opportunity for Alzheimer's drugs is expected to scale to US$6.4 bn by 2025 after being worth US$3.6 bn in 2017, exhibiting a CAGR of 7.5% between 2017 and 2025. By geography, it is anticipated that North America will continue to remain in its leading position even in the years to come on account of the presence of several leading players. The presence of prominent players in the region has helped in easy distribution of treatment channels thereby helping the market to grow in this region.
The North American Alzheimer's drugs market is expected to rise from US$1.7 bn in 2017 to reach an evaluation of US$3 bn by 2025, expanding at a CAGR of 7.3% from 2017 to 2025. The report predicts that the Asia Pacific Alzheimer's drugs Market will expand at the highest pace, exhibiting an 8.6% CAGR between 2017 and 2025. The market in Asia Pacific is estimated to be worth US$2.3 bn in 2025 after being worth US$1.1 bn in 2017.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1245
Combined Drug Therapy and Memantine to Make Significant Contribution to Revenues
On the basis of drug class, it is expected that memantine which led in the past will continue to do so in the years to come. TMR also predicts that combined drug treatment will also contribute significantly to the revenue of the global Alzheimer's drugs market in the coming years on account of the increasing realization and awareness about the efficiency of combined therapy. The increasing availability of combined therapy is also expected to be a reason behind its increased demand.
Support Received from Governments in Developed Nations to Drive Growth of Alzheimer's Drugs Market
One of the most important factors boosting the growth of the global Alzheimer's drugs market is the increasing prevalence of this disease among the elderly in the developed nations in the West. This market also receives a healthy support from governments across developed nations on account of the rising occurrence of neurodegenerative diseases in these nations. This in turn has led to the development of new drugs and therapies which has helped in the development and growth of the global Alzheimer's drugs market subsequently. The atmosphere is especially conducive for the Alzheimer’s drugs market in North America. In addition to this, the increasing awareness about neurodegenerative diseases among the developing nations and Asia Pacific will also fuel the growth of the global Alzheimer's drugs market in the years to come.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1245
High Cost of Advanced Drugs to Restrict the Growth of Market in Cost-sensitive Countries in Asia Pacific
As a result of limited awareness about Alzheimer's disease in several countries in the southeast of Asia, the research infrastructure in this part of the world remains underdeveloped for Alzheimer's. In addition to this the high cost of advanced drugs for the treatment of Alzheimer's has also deterred the cost sensitive regions and underdeveloped nations in Asia Pacific from adopting these drugs. On a bright side however, things are changing and governments are increasingly supporting mental care infrastructure across several developing nations of Asia Pacific and this is expected to overcome the impact of the above mentioned restraint and help the market to grow in this region in the years to come.
View Report -
http://www.transparencymarketresearch.com/alzheimers-drugs-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer’s Drugs Market to Record Sturdy Growth by 2025 here
News-ID: 1045120 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
